Clinical trial
Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease
NCT01363336 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- July 31, 2013
- Enrollment
- 1,882 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.